Rajak Kripa, Halder Anupam, Paghdar Smit, Desai Smruti P, Ruiz Jose, Goswami Rohan
Internal Medicine, University of Pittsburgh Medical Center (UPMC) Harrisburg, Harrisburg, USA.
Transplant, Mayo Clinic, Jacksonville, USA.
Cureus. 2023 Apr 25;15(4):e38114. doi: 10.7759/cureus.38114. eCollection 2023 Apr.
In advanced heart failure, refractory hemodynamically unstable ventricular tachycardia (VT) can be life-threatening. The utilization of short-term temporary mechanical circulatory support (MCS) has been described. Still, it is limited to the intra-aortic balloon pump (IABP) or Impella 2.5/CP (Abiomed Inc., Danvers, MA, USA) which may only provide up to 1-2.5 L/min of added support. Escalation of MCS therapies should be considered. Referrals to advanced tertiary heart transplant centers should be done early to afford patients the best chance at an optimal outcome, with the option for heart transplant evaluation if needed. We present a case of recalcitrant hemodynamically unstable VT complicated by cardiac arrest, eventually undergoing successful VT ablation while supported on veno-arterial extracorporeal membrane oxygenation (VA ECMO) and Impella 5.5 as a vent strategy in the extracorporeal membrane oxygenation-Impella (ECPELLA) configuration.
在晚期心力衰竭中,难治性血流动力学不稳定的室性心动过速(VT)可能危及生命。短期临时机械循环支持(MCS)的应用已有报道。然而,其仅限于主动脉内球囊泵(IABP)或Impella 2.5/CP(美国马萨诸塞州丹弗斯市的Abiomed公司),这些装置可能仅能提供高达1 - 2.5升/分钟的额外支持。应考虑升级MCS治疗方法。应尽早将患者转诊至高级三级心脏移植中心,以便为患者提供获得最佳治疗结果的最佳机会,并在需要时可选择进行心脏移植评估。我们报告一例难治性血流动力学不稳定的VT合并心脏骤停的病例,最终在静脉 - 动脉体外膜肺氧合(VA ECMO)和Impella 5.5支持下作为体外膜肺氧合 - Impella(ECPELLA)配置中的通气策略成功进行了VT消融。